glp-1 news november 25 2025 The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' GLP-1 Drugs: 2025 Pulse Survey

Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy

Specifically, when TOFO was administered as the first-line therapy and PIO was subsequently added, the combination showed significant additional improvements of MRI-PDFF and ALT concentrations vs

It is affiliated with a Japanese listed company (stock code: 8095)

In treatment development, repurposing drugs already approved for other conditions has the advantage of providing data and experience from previous research and practical use, Rebecca M

Mar 21, 2026 I'm a client and I have lost 24 lbs